Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應用
O-Methyl (4-Cyano-3-(trifluoromethyl)phenyl)carbamothioate is a related compound of Enzalutamide(M199800); recently approved for the treatment of castration-resistant prostate cancer.
參考文獻
Zhou, A., et al.: Chromatographia, 81, 1519 (2018);
滬ICP備17019645號
400-821-0725
